Development of a clockwork light source to enable cervical inspection by village health workers
© O'Mahony et al; licensee BioMed Central Ltd. 2002
Received: 17 May 2002
Accepted: 12 December 2002
Published: 12 December 2002
Cervical cancer can often be prevented by screening and may be curable if identified and treated in its early stages. However, 80% of new cases occur in less-developed countries where cervical cancer screening programmes are small-scale or non-existent. This is a human tragedy of great proportion, with many of those affected being young mothers. There is some evidence that cancerous or precancerous lesions may be detected by visual inspection with acetic acid (VIA) and field studies indicate that this technique is effective, safe and acceptable to women. However, the provision of a light source for inspection of the cervix presents a major problem in less-developed countries, where candles and torches often provide the only means of illumination. Our objective was to develop a light source based on clockwork technology, that required no batteries or external power source.
We adapted the design of a commercially available clockwork torch to provide a light source for cervical inspection. The light source was then tested under laboratory conditions in a comparison with other illumination methods typically used in this application.
The light source gave illuminance levels greater than those produced by any other method tested, and also had considerable advantages in terms of ease of use and safety.
This design is small, compact, effective and safe to use and promises a better and more affordable means of visualising the cervix. Further field trials of VIA are now required which incorporate this light source.
Cervical cancer can often be prevented by screening, and may be curable if identified and treated in its early stages. However, in most less-developed countries, cervical cancer screening programmes are small-scale or non-existent. Thus there are few opportunities for the diagnosis and treatment of precancerous cervical disease. It is estimated that in excess of 470,000 new cases of cervical cancer are diagnosed each year around the world, with more than 80% occurring in less developed countries . More than 233,000 women are dying from this disease each year and the morbidity is highest in those countries that are least equipped to deal with the problem. This is a human tragedy of great proportion, and many of those affected are young mothers.
There is some evidence that cancerous or precancerous lesions may be detected by simple inspection of the cervix . The cervix is first washed with acetic acid (vinegar) solution that causes precancerous changes in the cervix to turn white. Community (village) health workers are trained to detect the abnormality with the naked eye . This technique of visual inspection with acetic acid (VIA) may have potential advantages over traditional screening techniques, providing an immediate feedback of results and enabling prompt treatment . Field studies indicate that this technique is both sensitive and specific, and it may provide a cheap and acceptable means of screening for cervical cancer in poor-resource locations . A test and treat approach using VIA and Cryotherapy appears to be both safe and acceptable to women and providers, and has the potential to be an efficient method of cervical cancer prevention in these settings . However, the provision of a light source for inspection of the cervix presents a major problem in many rural communities. Many of these rural communities are without electricity, and candles and torches offer the only means of illumination (Personal Communication). In addition, portable power supplies and batteries are a desirable commodity and are rapidly diverted in other settings and applications.
Our objective was to develop a clockwork power source and light that required no batteries or external means of power. The light source needed to be small and compact enough to allow the health worker to illuminate and view the cervix, yet provide sufficient illumination to enable the identification of precancerous lesions. It was essential that the light source did not pose any hazard to either the patient or the health worker and that it was robust, and relatively inexpensive to deploy in less-developed countries. In addition, as it clips into the speculum it is likely to be contaminated by vaginal discharge and so needed to be waterproof to enable sterilisation (see figure 4). We believe that with simple adaptations to existing technology, we have achieved our objective.
Materials and Methods
Recent developments in dynamo-powered devices have brought us the clockwork radio, and more recently the clockwork torch. We adapted the design of commercially available clockwork torch technology to provide a light source which could be used independently of any external power supply and required no batteries.
The clockwork power source takes approximately 6 hrs to fully charge the batteries, giving approximately 2 1/2 hours of continuous use. It can also be used directly from the clockwork spring in an emergency setting, whereby 60 turns on the handle will provide sufficient charge to operate the light source for around 3 minutes.
In order to assess the effectiveness of the light source, a comparison was made with a range of other illumination methods that may be typically used for this application: namely a 100 W-desk lamp; a 40 W-desk lamp; a torch (0.5 W); a small compact torch (0.75 W); and a candle with and without a metal reflector.
The human eye responds to a narrow band of the electromagnetic spectrum, typically 400–700 nm with a peak response at 555 nm. In order to compare the different light sources it is essential that account be taken of the response of the human eye.
Typical illuminance values
Illuminance (typical lux)
Cervical cancer is the third most common cancer in the world. Screening programmes aim to detect cervical cancer in its early stages and make successful treatment more likely, with the possibility of reducing the incidence and mortality. In countries where regular cervical cancer screening is available, death rates have been reduced. However, cervical cancer remains the leading cause of death from cancer among women in less developed countries, where cervical cancer screening programmes are non-existent or fragmented at best .
Cervical cancer screening is a complex process. Less developed countries often face economic, social and cultural constraints which prevent the implementation of organised cervical cytology screening. A recent analysis of cervical cancer screening strategies for low-resource settings found VIA to be cost-effective ($39 per year of life saved) and when coupled with immediate treatment it reduced the incidence of cervical cancer by 26% . However, compared to cytology, VIA is less specific with low positive predictive value for high-grade disease . In their report from Zimbabwe, The University of Zimbabwe/JHPIEGO Cervical Cancer Project suggested that higher test quality for VIA could be achieved with better lighting, standardised training and better service delivery conditions .
The light source was the best amongst the illumination methods tested. Its illuminance was greater than that of the torch, which is still commonly used for gynaecological examination even in UK hospitals. It is not simply the power output of the light source but also how compact it is that determines the measured illuminance at the cervix. The 100 W and 40 W lamps are certainly the brightest sources used but they are large, unwieldy and must be placed behind the observer. The light source has the bulb detached from the power source, so that its size is only that of the clip and bulb. Hence it does not impede the view of the health worker. In addition the speculum clip means that the light source does not need to be held, leaving the health worker's hands free (Figure 4).
This design promises a better and more affordable means of visualising the cervix, and further field trials of VIA are required which incorporate this light source.
List of Abbreviations
visual inspection (of the cervix) with acetic acid
This paper is dedicated to Richard Johanson who died prior to publication. We are grateful to the Rotary Club for their support and encouragement. Linda Lucking prepared the manuscript.
- Parkin DM, Whelam SL, Ferlay J, Raymond L, Young J: Cancer incidence in five continents. IARC Scientific Publication No. 143, Lyon. 1997Google Scholar
- Kitchner HC, Symonds P: Detection of cervical intraepithelial neoplasia in developing countries (Commentary). Lancet. 1999, 353: 856-857. 10.1016/S0140-6736(98)00417-6.View ArticleGoogle Scholar
- University of Zimbabwe/JHPIEGO Cervical Cancer Project: Visual inspection with acetic acid for cervical-cancer screening: test qualities in a primary-care setting. Lancet. 1999, 353: 869-873. 10.1016/S0140-6736(98)07033-0.View ArticleGoogle Scholar
- Cervical cancer control in developing countries: memorandum from a WHO meeting. Bull World Health Organ. 1996, 74: 345-351.
- Sankaranarayanan R, Wesley R, Somanathan T, Dhakad N, Shyamalakumary B, Amma NS, Parkin DM, Nair MK: Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors. Cancer. 1998, 83: 2150-2156. 10.1002/(SICI)1097-0142(19981115)83:10<2150::AID-CNCR13>3.3.CO;2-S.View ArticlePubMedGoogle Scholar
- Limpaphayom K, Lumbiganon P, Gaffikin L, Worakamin S, Srisupundit S, Ringers P, Blumental P: Safety and acceptability of visual inspection using acetic acid (VIA) and cryotherapy for cervical cancer prevention in ROI-ET Province, Thailand. Annual Scientific Meeting of the RANZCOG, Melbourne, Australia, November. 2001, Book of Abstracts 41.Google Scholar
- Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC: Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness. JAMA. 2001, 285 (24): 3107-3115. 10.1001/jama.285.24.3107.View ArticlePubMedGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6874/2/12/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.